CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Clinicopathological features and outcome of pediatric non-lymphoblastic non-hodgkins lymphoma - an institutional experience.

Author: 
Arun Kumar, *Prerana Nesargi, Nuthan Kumar, Appaji, L. Aruna Kumari B.S. and Aarthi, N.
Subject Area: 
Health Sciences
Abstract: 

Background: Non-Hodgkin’s Lymphoma (NHL) of childhood accounts approximately 60% of lymphomas and malignant lymphomas are the third most commonest group after leukaemia, brain tumors. Need for the study: There exists paucity of data on paediatric Non Lymphoblastic Non Hodgkin’s Lymphoma from developing countries, we conducted this study to know the clinic-pathological profile, treatment and survival outcome of these children. Design/Methods: This study is a retrospective descriptive analytical study of all the Non Lymphoblastic Non Hodgkins Lymphoma patients diagnosed and treated at department of paediatric oncology, Kidwai cancer institute from January 2009 to December 2014. Results: Seventy one patients aged less than 15 years were included in this study, there were males (n=53) and females (n=18) with male: female ration being 3:1. The most common site involved at the time of presentation was intrabdominal (n=32,45%) The most common pathological subtype was Burkitt lymphoma(37,52%) followed by ALCL(20,28%),DLBCL(14,20%),majority of children were stage lll (n=54,76%) as per St Judes staging for Non Hodgkins Lymphoma. 42 (71.2%) patients were treated with MCP 842 and 17(28.8%) were treated COMP protocols. The 3 year DFS was for Burkitt, ALCL, DLBCL were 90%, 66.7%,90% respectively. Conclusion: The outcomes in non lymphoblastic NHL from our centre were almost equivalent to western data, short intensive chemotherapy and good supportive care has pivotal role in the management of these tumours even in advanced stages of the tumours.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran